Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

6ea03bc22310ede262fc8192ea07859d408c9061c213e514fb096ea79c33d156

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

b2376b597aba1a9da00516a7bbb3b06a335f7e5172c0edfeb0ec1404578dcde9

Total Revenue (USD)

Cost of Goods Sold (COGS) (USD)

Selling, General, and Administrative Expenses (SG&A) (USD)

Research and Development (R&D) (USD)

Depreciation and Amortization (D&A) (USD)

Interest Expense (USD)

Operating Income (EBIT) (USD)

Net Income (USD)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

9e85ca852b94e3f339467e345ead4aca43dcb4248efecceeae02e6dee578e5e1

Research and Development Expenses (USD, thousands)

Acquired In-Process Research and Development Expenses (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Total Operating Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Other Income (USD, thousands)

Total Other Income (USD, thousands)

Net Loss (USD, thousands)

Unrealized Gain (Loss) on Available-for-Sale Securities, Net of Tax (USD, thousands)

Comprehensive Loss (USD, thousands)

Net Loss per Share Attributable to Common Stockholders, Basic and Diluted (USD)

Weighted-Average Common Shares Outstanding, Basic and Diluted (thousands)

012e5a0ce17cd4a27b5e90caaf7274c42748f30c16ac36a20a59d0fb78289ebf

Accounts Receivable, Net (USD, thousands)

Inventory, Net (USD, thousands)

Prepaid Expenses and Other Current Assets (USD, thousands)

Total Current Assets (USD, thousands)

Property and Equipment, Net (USD, thousands)

Operating Lease Right-of-Use Assets (USD, thousands)

Other Non-Current Assets (USD, thousands)

Total Assets (USD, thousands)

Operating Lease Liabilities, Current (USD, thousands)

Other Current Liability (USD, thousands)

Total Current Liabilities (USD, thousands)

Operating Lease Liabilities, Non-Current (USD, thousands)

Other Non-Current Liability (USD, thousands)

Total Liabilities (USD, thousands)

Accumulated Other Comprehensive Loss (USD, thousands)

Accumulated Deficit (USD, thousands)

Total Stockholders’ Equity (USD, thousands)

Total Liabilities, Preferred Stock and Stockholders’ Equity (USD, thousands)

5aef42f5fa9d445f00a5b15fff76a0adab6fd14cae3b56ea60dd68ad4e7ac949

Product Revenue

- PEMGARDA

Total Revenue

f3dfd19522a38afbd60b8e2906e7b9d6454b0c4b672121dc002f7ed9eeb13351

Invivyd Inc (IVVD)

Financials